Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VPM1002 Vaccination or BCG Revaccination in Pre-Adolescents With and Without HIV in South Africa
NCT05539989Phase 2Withdrawn
- Sponsor
- IMPAACT Network
- Start
- Dec 2026
- Primary completion
- Dec 2026
- Modality
- Prophylactic Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of VPM1002 in Tuberculosis (TB), sponsored by IMPAACT Network. Planned start Dec 2026; status: withdrawn.
02
Drugs
VPM1002
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT05539989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05539989.